Financial Services >> Analyst Interviews >> September 23, 2003
Daniel C. Lubin is a Managing Partner of Radius Ventures, LLC, which
acts as the investment advisor to both Radius Funds. Previously, Mr.
Lubin was a Director in the Investment Banking Division at Schroder
Wertheim & Co., where he shared responsibility for managing the Health
Care Group. He co-founded and was a Managing Director of KBL Healthcare
Inc., a health and life sciences venture capital and investment banking
organization, and served as President and Chief Operating Officer of KBL
Healthcare Acquisition Corp., a publicly-traded strategic acquisition
fund. His prior affiliations include Manufacturers Hanover Trust
Company, where he served as a lending officer in the International
Banking Division, and the Center for Strategic and International
Studies, where he served as Special Assistant to the Chairman. He was a
Founder of Cambridge Heart, Inc., a cardiology device company that went
public in 1996. Mr. Lubin currently serves on the Board of Directors of
Phylogix, Inc., and EyeTel Imaging, Inc., each portfolio companies of
Radius. He also serves on the National Leadership Council of The
Haverford School. He earned a BS cum laude in Foreign Service from the
Georgetown University School of Foreign Service and an MBA with honors
from Harvard Business School. Profile
Mr. Lubin: Radius Ventures is a health and life sciences fund based in
New York, focused mainly on early stage venture capital.
